Pre-treatment with Bifidobacterium breve UCC2003 modulates Citrobacter rodentiuminduced colonic inflammation and organ specificity

Microbiology (United Kingdom)

Volumn 158, Issue 11, 2012, Pages 2826-2834

  Collins, James W ^a   Akin, Ali R ^b   Kosta, Artemis ^a   Zhang, Ning ^b   Tangney, Mark ^c   Francis, Kevin P ^b   Frankel, Gad ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b PERKINELMER INC   (United States)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BIFIDOBACTERIUM BREVE; BIOLUMINESCENCE; C57BL 6 MOUSE; CITROBACTER RODENTIUM; COLITIS; CONTROLLED STUDY; ELECTRON MICROSCOPY; FECES ANALYSIS; FEMALE; HISTOPATHOLOGY; HYPERPLASIA; IMAGING; IMMUNOFLUORESCENCE; INFECTION PREVENTION; INTESTINE CRYPT; MICRO-COMPUTED TOMOGRAPHY; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING; TREATMENT OUTCOME;

ANIMALS; BIFIDOBACTERIUM; CITROBACTER RODENTIUM; COLON; COLONIC DISEASES; ENTEROBACTERIACEAE INFECTIONS; FEMALE; MICE; MICE, INBRED C57BL; ORGAN SPECIFICITY; PROBIOTICS;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM BREVE; CITROBACTER; CITROBACTER RODENTIUM; MUS;

EID: 84868327350     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.060830-0     Document Type: Article

References (38)

1. Bernet-Camard, M. F., Liévin, V., Brassart, D., Neeser, J. R., Servin, A. L. & Hudault, S. (1997). The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo. Appl Environ Microbiol 63, 2747-2753.
2. Chen, C. C., Louie, S., Shi, H. N. & Walker, W. A. (2005). Preinoculation with the probiotic Lactobacillus acidophilus early in life effectively inhibits murine Citrobacter rodentium colitis. Pediatr Res 58, 1185-1191.
3. Chen, X., Xu, J., Shuai, J., Chen, J., Zhang, Z. & Fang, W. (2007). The S-layer proteins of Lactobacillus crispatus strain ZJ001 is responsible for competitive exclusion against Escherichia coli O157:H7 and Salmonella typhimurium. Int J Food Microbiol 115, 307-312.
4. Chen, C. C., Chiu, C. H., Lin, T. Y., Shi, H. N. & Walker, W. A. (2009). Effect of probiotics Lactobacillus acidophilus on Citrobacter rodentium colitis: the role of dendritic cells. Pediatr Res 65, 169-175.
5. Contag, C. H., Contag, P. R., Mullins, J. I., Spilman, S. D., Stevenson, D. K. & Benaron, D. A. (1995). Photonic detection of bacterial pathogens in living hosts. Mol Microbiol 18, 593-603.
6. Corr, S. C., Li, Y., Riedel, C. U., O'Toole, P. W., Hill, C. & Gahan, C. G. (2007). Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc Natl Acad Sci U S A 104, 7617-7621.
7. Crepin, V. F., Girard, F., Schüller, S., Phillips, A. D., Mousnier, A. & Frankel, G. (2010). Dissecting the role of the Tir: Nck and Tir: IRTKS/IRSp53 signalling pathways in vivo. Mol Microbiol 75, 308-323.
8. Cronin, M., Morrissey, D., Rajendran, S., El Mashad, S. M., van Sinderen, D., O'Sullivan, G. C. & Tangney, M. (2010). Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors. Mol Ther 18, 1397-1407.
9. Cronin, M., Akin, A. R., Collins, S. A., Meganck, J., Kim, J. B., Baban, C. K., Joyce, S. A., van Dam, G. M., Zhang, N. & other authors (2012). High resolution in vivo bioluminescent imaging for the study of bacterial tumour targeting. PLoS ONE 7, e30940.
10. D'Arienzo, R., Maurano, F., Mazzarella, G., Luongo, D., Stefanile, R., Ricca, E. & Rossi, M. (2006). Bacillus subtilis spores reduce susceptibility to Citrobacter rodentium-mediated enteropathy in a mouse model. Res Microbiol 157, 891-897.
11. Doyle, T.C., Burns, S. M. & Contag, C. H. (2004). In vivo bioluminescence imaging for integrated studies of infection. Cell Microbiol 6, 303-317.
12. Dundas, S., Todd, W. T., Neill, M. A. & Tarr, P. I. (2005). Using antibiotics in suspected haemolytic-uraemic syndrome: antibiotics should not be used in Escherichia coli O157:H7 infection. BMJ 330, 1209, author reply 1209.
13. Fanning, S., Hall, L. J., Cronin, M., Zomer, A., MacSharry, J., Goulding, D., O'Connell Motherway, M., Shanahan, F., Nally, K. & other authors (2012). Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. Proc Natl Acad Sci U S A 109, 2108-2113.
14. Felis, G. E. & Dellaglio, F. (2007). Taxonomy of Lactobacilli and Bifidobacteria. Curr Issues Intest Microbiol 8, 44-61.
15. FAO (2001). Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic acid Bacteria. http://www.who. int/foodsafety/publications/fs_management/probiotics/en/index.html.
16. Fuller, R. (1992). Probiotics: the Scientific Basis. Chapman & Hall.
17. Gareau, M. G., Wine, E., Reardon, C. & Sherman, P. M. (2010). Probiotics prevent death caused by Citrobacter rodentium infection in neonatal mice. J Infect Dis 201, 81-91.
18. Girard, F., Dziva, F., van Diemen, P., Phillips, A. D., Stevens, M. P. & Frankel, G. (2007). Adherence of enterohemorrhagic Escherichia coli O157, O26, and O111 strains to bovine intestinal explants ex vivo. Appl Environ Microbiol 73, 3084-3090.
19. Hardy, J., Francis, K. P., DeBoer, M., Chu, P., Gibbs, K. & Contag, C. H. (2004). Extracellular replication of Listeria monocytogenes in the murine gall bladder. Science 303, 851-853.
20. Health Protection Agency (2011). E. coli O157 Annual Totals. http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb_C/12491 13624846.
21. Huebner, E. S. & Surawicz, C. M. (2006). Probiotics in the prevention and treatment of gastrointestinal infections. Gastroenterol Clin North Am 35, 355-365.
22. Johnson-Henry, K. C., Nadjafi, M., Avitzur, Y., Mitchell, D. J., Ngan, B. Y., Galindo-Mata, E., Jones, N. L. & Sherman, P. M. (2005). Amelioration of the effects of Citrobacter rodentium infection in mice by pretreatment with probiotics. J Infect Dis 191, 2106-2117.
23. Jones, S. E. & Knight, K. L. (2012). Bacillus subtilis-mediated protection from Citrobacter rodentium-associated enteric disease requires espH and functional flagella. Infect Immun 80, 710-719.
24. Kuo, C., Coquoz, O., Troy, T. L., Xu, H. & Rice, B. W. (2007). Threedimensional reconstruction of in vivo bioluminescent sources based on multispectral imaging. J Biomed Opt 12, 024007.
25. McGannon, C. M., Fuller, C. A. & Weiss, A. A. (2010). Different classes of antibiotics differentially influence Shiga toxin production. Antimicrob Agents Chemother 54, 3790-3798.
26. Medellin-Peña, M. J., Wang, H., Johnson, R., Anand, S. & Griffiths, M. W. (2007). Probiotics affect virulence-related gene expression in Escherichia coli O157: H7. Appl Environ Microbiol 73, 4259-4267.
27. Mundy, R., MacDonald, T. T., Dougan, G., Frankel, G. & Wiles, S. (2005). Citrobacter rodentium of mice and man. Cell Microbiol 7, 1697-1706.
28. Panos, G. Z., Betsi, G. I. & Falagas, M. E. (2006). Systematic review: are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection? Aliment Pharmacol Ther 24, 731-742.
29. Picard, C., Fioramonti, J., Francois, A., Robinson, T., Neant, F. & Matuchansky, C. (2005). Review article: bifidobacteria as probiotic agents-physiological effects and clinical benefits. Aliment Pharmacol Ther 22, 495-512.
30. Preidis, G. A., Hill, C., Guerrant, R. L., Ramakrishna, B. S., Tannock, G. W. & Versalovic, J. (2011). Probiotics, enteric and diarrheal diseases, and global health. Gastroenterology 140, 8-14.
31. Rodrigues, D. M., Sousa, A. J., Johnson-Henry, K. C., Sherman, P. M. & Gareau, M. G. (2012). Probiotics are effective for the prevention and treatment of Citrobacter rodentium-induced colitis in mice. J Infect Dis 206, 99-109.
32. Servin, A. L. (2004). Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev 28, 405-440.
33. Servin, A. L. & Coconnier, M. H. (2003). Adhesion of probiotic strains to the intestinal mucosa and interaction with pathogens. Best Pract Res Clin Gastroenterol 17, 741-754.
34. Szittner, R. & Meighen, E. (1990). Nucleotide sequence, expression, and properties of luciferase coded by lux genes from a terrestrial bacterium. J Biol Chem 265, 16581-16587.
35. Tarr, P. I., Gordon, C. A. & Chandler, W. L. (2005). Shiga-toxinproducing Escherichia coli and haemolytic uraemic syndrome. Lancet 365, 1073-1086.
36. Wiles, S., Clare, S., Harker, J., Huett, A., Young, D., Dougan, G. & Frankel, G. (2004). Organ specificity, colonization and clearance dynamics in vivo following oral challenges with the murine pathogen Citrobacter rodentium. Cell Microbiol 6, 963-972.
37. Wiles, S., Dougan, G. & Frankel, G. (2005). Emergence of a 'hyperinfectious' bacterial state after passage of Citrobacter rodentium through the host gastrointestinal tract. Cell Microbiol 7, 1163-1172.
38. Wu, X., Vallance, B. A., Boyer, L., Bergstrom, K. S., Walker, J., Madsen, K., O'Kusky, J. R., Buchan, A. M. & Jacobson, K. (2008). Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors. Am J Physiol Gastrointest Liver Physiol 294, G295-G306.